Research

Adenovirus-associated pneumonia in South African children: Presentation, clinical course and outcome

M Zampoli, Z Mukuddem-Sablay

Abstract


Background. Viruses have emerged as important aetiological agents of childhood pneumonia.

Objective. To investigate the clinical presentation, severity and outcome of adenovirus-associated pneumonia (AVP) in children.

Methods. A retrospective analysis of AVP cases over 12 months was performed, including demographic, clinical course and outcome (death, persistent lung disease (PLD)) data.

Results. Two hundred and six AVP cases (median age 12 months, interquartile range 6 - 24) were identified; 70 children (34.0%) were malnourished and 14 (6.8%) were HIV-infected. Twenty-nine children (14.1%) developed PLD, which was associated with hypoxia at presentation in 26 cases (89.7%; p=0.01) and necessitated admission to the intensive care unit (ICU) in 18 (62.1%; p<0.01); 18/206 children (8.7%) died. Admission to the ICU (odds ratio (OR) 8.3, 95% confidence interval (CI) 2.3 - 29.0) and a positive blood culture (OR 11.2, 95% CI 2.3 - 54.1) were independent risk factors for mortality.

Conclusions. Adenovirus is a potential cause of pneumonia and PLD in young children in South Africa. ICU admission and a positive blood culture were associated with poor outcome.


Authors' affiliations

M Zampoli, Department of Paediatrics and Child Health, Red Cross War Memorial Children’s Hospital and Faculty of Health Sciences, University of Cape Town, South Africa

Z Mukuddem-Sablay, Department of Paediatrics and Child Health, Red Cross War Memorial Children’s Hospital and Faculty of Health Sciences, University of Cape Town, South Africa

Full Text

PDF (86KB)

Keywords

Adenovirus; Pneumonia; Children; Chronic lung disease

Cite this article

South African Medical Journal 2017;107(2):123-126. DOI:10.7196/SAMJ.2017.v107i2.11451

Article History

Date submitted: 2017-01-30
Date published: 2017-01-30

Article Views

Abstract views: 1538
Full text views: 1021

Comments on this article

*Read our policy for posting comments here